PTC Therapeutics (PTCT) reported $211.01 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 7.2$0.20 for the same period compares to -$1.39 a year ago.The reported revenue represents a surprise of +20.17$175.6 million. With the consensus EPS estimate being -$1.19, the EPS surprise was +116.81%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectation ...